CRISPR NEWS

U.S. Patent and Trademark Office issues 6th CRISPR patent to CVC June 4, 2019

On June 4, 2019 the U.S. Patent and Trademark Office issued U.S. Patent No. 10,308,961 (‘the ‘961 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier (collectively, “CVC”). The patent covers methods of editing genes and controlling gene expression in a cell, including enabling genes to be modified, activated or repressed. These methods are not limited to single guide RNA and can be applied to both prokaryotic and eukaryotic cells. The ‘961 patent claims earliest priority to a U.S. provisional application, filed by CVC on May 25, 2012.

View Press Release

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
Read moreArrow-down